Sarah ElayeeteBHUN (MaK); MPH (MaK) |
||||||
ABOUT THE FELLOWSarah Elayeete is a fully-fledged field epidemiologist with a master’s degree in Public health and a background in community Health Science. Sarah has particular interest in HIV project implementation. During the Field Epidemiology fellowship training, Sarah was attached to the National AIDS Control Program (ACP), a department within Uganda Ministry of Health. Through the in-service training she attained skills in leadership, outbreak investigation and response. She led two outbreak investigations and participated in one other. She was involved in case investigations during the 2022 Ebola outbreak. Achievements at the Host Site
Fellowship program specific achievementsLed two outbreak investigations:
Participated in three other outbreak investigations:
Trained health workers in West Nile region on normal channels development Facilitated frontline training of cohort 14 in Soroti and Mbale District Participated in the EVD outbreak response in Central region Supervised immunization defaulter tracking exercise in Hoima and Bukomasibi Districts August-October. Participated in the EVD outbreak response and data analysis Conference presentations International
National
Written Communication
Summary of Epidemiological Study:Title: Comparative epidemiologic analysis of COVID-19 Patients during the first and second waves of COVID-19 inUganda, 2020-2021 Background: Uganda has had two major waves of COVID-19, the first in late 2020 and the second in mid-2021. In March 2021, the country began offering Astra-Zeneca COVID-19 vaccine. In late April 2021, the country entered a larger, second wave caused primarily by the SARS-CoV-2 Delta variant. Anecdotal reports suggested that younger persons were more prone to develop severe disease during the second wave than the first. We compared epidemiologic characteristics of hospitalized (HP) and non-hospitalized (NHP) COVID-19 patients in the two major COVID-19 waves in Uganda. Methods: We defined ‘Wave 1’ as November-December 2020, and ‘Wave 2’ as April-June 2021. At each of two major Kampala hospitals, we collected medical records data for 100 randomly-selected HP in Wave 1 and 100 in Wave 2. We retrieved contact information for randomly-selected, PCR-confirmed NHP (200 for each wave) from laboratory records and interviewed them by phone. Demographic, clinical, and self-reported vaccination data were collected from patients or next-of-kin. Results: A higher proportion of HP in Wave 2 than Wave 1 were female (46% vs. 27%, p=0.0001), and more Wave 2 than Wave 1 had severe disease or died (65% vs. 31%, p<0.0001). NHP in Wave 2 were younger than those in Wave 1 (median age 27 vs. 35 years, p=0.08). Median age of HP was significantly older than NHP in Wave 2 (median age 47 vs. 27 years, p<0.0001) but not Wave 1 (median age 42 vs. 35 years, p=0.15). Increasing age was associated with hospitalization in both waves, but the association was stronger in Wave 2 than Wave 1 (p<0.0001). No patients were fully vaccinated. Conclusion: Demographic and epidemiologic characteristics of hospitalized and non-hospitalized patients between and within Waves 1 and 2 of the pandemic in Uganda differed. Different variants of COVID-19 should be studied independently. Key lessons learnt during the fellowshipDuring my two years in the fellowship program, I learnt and developed the following skills:
Next StepsWith the skills and competencies gained, I hope to continue serving within the Ministry of Health or related organizations. I aspire to work to realization of improved health for key and priority populations and prompt response to public health emergencies and threats. Pictorial
|